Jacques Dumas, Chief Scientific Officer at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 17,500 shares at $6.03 ($106K) on 2017-10-31, disclosed to the SEC on 2017-11-02.
Open-market sale of $106k TTPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.03 | 8,750 | $53K | 50.0% |
| 2 | $6.03 | 8,750 | $53K | 50.0% |
| Total | $6.03 avg | 17,500 | $106K | 100% |
| Filing → |
| TTPH | SELL | 2018-01-11 | $45K | — | Filing → |
| TTPH | SELL | 2017-08-24 | $105K | — | Filing → |
| TTPH | SELL | 2017-08-21 | $42K | — | Filing → |